Healthways Inc. (NASDAQ:HWAY)’s share price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $17.47 and last traded at $16.24, with a volume of 4,985,348 shares. The stock had previously closed at $12.18.

A number of equities analysts have recently issued reports on HWAY shares. Barrington Research reiterated a “buy” rating on shares of Healthways in a research report on Saturday, April 30th. FBR & Co reiterated a “buy” rating on shares of Healthways in a research report on Friday, April 29th. Zacks Investment Research upgraded shares of Healthways from a “sell” rating to a “hold” rating in a research report on Tuesday, May 3rd. Finally, Jefferies Group reiterated a “hold” rating and set a $13.00 target price on shares of Healthways in a research report on Tuesday, May 3rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $13.40.

The firm has a 50 day moving average price of $12.01 and a 200-day moving average price of $11.48. The firm’s market capitalization is $575.71 million.

Healthways (NASDAQ:HWAY) last released its quarterly earnings results on Thursday, April 28th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by $0.06. The company had revenue of $189.20 million for the quarter, compared to analyst estimates of $185.68 million. During the same quarter last year, the company posted ($0.05) earnings per share. The business’s revenue for the quarter was down .4% compared to the same quarter last year. On average, analysts predict that Healthways Inc. will post $0.24 EPS for the current year.

A number of institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Arbitrage SA raised its position in Healthways by 37.1% in the fourth quarter. BNP Paribas Arbitrage SA now owns 80,127 shares of the company’s stock valued at $1,031,000 after buying an additional 21,702 shares in the last quarter. American Capital Management Inc. raised its position in Healthways by 4.0% in the fourth quarter. American Capital Management Inc. now owns 896,380 shares of the company’s stock valued at $11,536,000 after buying an additional 34,590 shares in the last quarter. Finally, Royce & Associates LLC raised its position in Healthways by 25.2% in the fourth quarter. Royce & Associates LLC now owns 796,704 shares of the company’s stock valued at $10,254,000 after buying an additional 160,500 shares in the last quarter.

Healthways, Inc (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.